ANN JANIK: Open Payments
NPI 1134199862 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,423 in 72 payments from 19 companies in 2025. Trend: 2023 $742 · 2024 $1,306 · 2025 $1,423
Food & beverage: $1,423
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 12 | $229 |
| ABBVIE INC. | 17 | $222 |
| GENZYME CORPORATION | 7 | $182 |
| Regeneron Healthcare Solutions, Inc. | 3 | $100 |
| Arcutis Biotherapeutics, Inc. | 5 | $94 |
| Novartis Pharmaceuticals Corporation | 3 | $74 |
| UCB, Inc. | 3 | $71 |
| LEO Pharma Inc. | 3 | $67 |
| PFIZER INC. | 3 | $57 |
| Amgen Inc. | 3 | $50 |
Products named: DUPIXENT, TREMFYA, SKYRIZI, RINVOQ, Zoryve, Bimzelx, ADBRY, CIBINQO.
Industry payments across AZ — which companies pay providers there.
